|
?:authorAffiliation
|
-
[\'Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.\', \'Department of Medicine, University of Cambridge, Cambridge, UK.\', \'Division of Infection and Immunity, University College London, London WC1E 6BT, UK.\', \'Diagnostics for the Real World EU, Chesterford Research Park, UK.\', \'Department of Pathology, University of Cambridge, Cambridge, UK.\', \'NIHR Cambridge Clinical Research Facility, Cambridge, UK.\', \'Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent, Kent, UK.\', \'Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.\', \'Clinical Microbiology & Public Health Laboratory, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.\', \'Department of Statistics, Athens University of Economics and Business, Athens, Greece.\', \'Cambridge Clinical Trials Unit-Cancer Theme, University of Cambridge, Cambridge, UK.\', \'National Institutes for Health Research Cambridge Biomedical Research Centre, Cambridge, UK.\', \'Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.\', \'Department of Emergency Medicine, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.\', \'Africa Health Research Institute, Durban, South Africa.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}